FIELD: medicine. SUBSTANCE: method involves administering biphosphonate bone resorption inhibitor like sodium alendronate to patients having orthopedic devices implanted. The preparations are administered per os and parenterally and into a bone tissue area adjacent to the prosthesis. EFFECT: alleviated pain; prevented orthopedic prosthesis loosening. 15 cl, 1 dwg
Authors
Dates
2000-12-27—Published
1995-04-17—Filed